SZodixStudyAcademic Library
ShelvesOpen access
Study · an open academic library·Metadata from OpenAlex (CC0)·Shelves·OpenAlex metadata, de-duplicated
Ongoing measures to enhance the efficiency of prescribing of proton pump inhibitors and statins in The Netherlands: influence and future implications
8 references·4 citing·37 second hop
Ongoing measures to enhance the efficiency of prescribing of proton pump inhibitors and statins in The Netherlands: influence and future implications (2012)Ongoing measures to enhance the efficienc…The ‘Wise List’– A Comprehensive Concept to Select, Communicate and Achieve Adherence to Recommendations of Essential Drugs in Ambulatory Care in Stockholm (2011)The ‘Wise List’– A Comprehens…Policies to Enhance Prescribing Efficiency in Europe: Findings and Future Implications (2011)Policies to Enhance Prescribi…Effects of purchaser competition in the Dutch health system: is the glass half full or half empty? (2011)Effects of purchaser competit…Risk sharing arrangements for pharmaceuticals: potential considerations and recommendations for European payers (2010)Risk sharing arrangements for…Ongoing pharmaceutical reforms in France (2010)Ongoing pharmaceutical reform…Comparing policies to enhance prescribing efficiency in Europe through increasing generic utilization: changes seen and global implications (2010)Comparing policies to enhance…Soft regulations in pharmaceutical policy making (2009)Soft regulations in pharmaceu…Multifaceted national and regional drug reforms and initiatives in ambulatory care in Sweden: global relevance (2009)Multifaceted national and reg…The prescribing of generic medicines in Nigeria: knowledge, perceptions and attitudes of physicians (2015)The prescribing of generic me…Prescribing efficiency of proton pump inhibitors in China: influence and future directions (2015)Prescribing efficiency of pro…Reforms and initiatives in Scotland in recent years to encourage the prescribing of generic drugs, their influence and implications for other countries (2013)Reforms and initiatives in Sc…Generic Medicines: Solutions for a Sustainable Drug Market? (2013)Generic Medicines: Solutions …Use of Generics—A Critical Cost Containment Measure for All Healthcare Professionals in Europe? (2010)Estonia: Health System Review. (2013)Disinvestment and Value-Based Purchasing Strategies for Pharmaceuticals: An International Review (2015)Institutionalized Organizations: Formal Structure as Myth and Ceremony (1977)The Audit Society: Rituals of Verification (1998)The Audit Society: Rituals of Verification (1999)Influence of demand-side measures to enhance renin–angiotensin prescribing efficiency in Europe: implications for the future (2011)Rationing and competition in the Dutch health-care system (2005)What Do We Know About Competition and Quality in Health Care Markets? (2006)Universal Mandatory Health Insurance In The Netherlands: A Model For The United States? (2008)The politics of health-care reform in the Netherlands since 2006 (2011)Swiss and Dutch “consumer-driven health care”: Ideal model or reality? (2012)Productivity and quality of Dutch hospitals during system reform (2015)Using Effectiveness and Cost-effectiveness to Make Drug Coverage Decisions (2009)Health systems in transition. (2010)Managed entry agreements for pharmaceuticals: the European experience (2013)Cancer drugs in 16 European countries, Australia, and New Zealand: a cross-country price comparison study (2015)How Can Pricing and Reimbursement Policies Improve Affordable Access to Medicines? Lessons Learned from European Countries (2017)The Swedish Council on Technology Assessment in Health Care (1989)Are new models needed to optimize the utilization of new medicines to sustain healthcare systems? (2014)Diffusion of Innovations 1 (2019)Cochrane Database of Systematic Reviews (2011)Different initiatives across Europe to enhance losartan utilization post generics: impact and implications (2014)European Healthcare Policies for Controlling Drug Expenditure (2003)Patients’ attitudes towards and experiences of generic drug substitution in Norway (2006)Patients’ Perceptions Of Generic Medications (2009)Demand-side policies to encourage the use of generic medicines: an overview (2013)Fixed dose drug combinations – are they pharmacoeconomically sound? Findings and implications especially for lower- and middle-income countries (2020)Encouraging the use of generic medicines: implications for transition economies. (2002)Clinical Equivalence of Generic and Brand-Name Drugs Used in Cardiovascular Disease (2008)Medicine prices, availability, and affordability in 36 developing and middle-income countries: a secondary analysis (2008)Rapid Assessment of the Potential Paucity and Price Increases for Suggested Medicines and Protection Equipment for COVID-19 Across Developing Countries With a Particular Focus on Africa and the Implications (2021)Ongoing Initiatives to Improve the Quality and Efficiency of Medicine Use within the Public Healthcare System in South Africa; A Preliminary Study (2017)Barriers for Access to New Medicines: Searching for the Balance Between Rising Costs and Limited Budgets (2018)Pharmaceutical policies in European countries in response to the global financial crisis (2011)Policies to promote use of generic medicines in low and middle income countries: A review of published literature, 2000–2010 (2012)Medicine Shortages: Gaps Between Countries and Global Perspectives (2019)
this work references cited by second hop

References

  • 2010Risk sharing arrangements for pharmaceuticals: potential considerations and recommendations for European payers255 cited
  • 2011The ‘Wise List’– A Comprehensive Concept to Select, Communicate and Achieve Adherence to Recommendations of Essential Drugs in Ambulatory Care in Stockholm224 cited
  • 2010Comparing policies to enhance prescribing efficiency in Europe through increasing generic utilization: changes seen and global implications153 cited
  • 2009Multifaceted national and regional drug reforms and initiatives in ambulatory care in Sweden: global relevance150 cited
  • 2011Policies to Enhance Prescribing Efficiency in Europe: Findings and Future Implications113 cited
  • 2010Ongoing pharmaceutical reforms in France108 cited
  • 2009Soft regulations in pharmaceutical policy making97 cited
  • 2011Effects of purchaser competition in the Dutch health system: is the glass half full or half empty?70 cited

Cited by

  • 2013Reforms and initiatives in Scotland in recent years to encourage the prescribing of generic drugs, their influence and implications for other countries86 cited
  • 2015The prescribing of generic medicines in Nigeria: knowledge, perceptions and attitudes of physicians79 cited
  • 2013Generic Medicines: Solutions for a Sustainable Drug Market?67 cited
  • 2015Prescribing efficiency of proton pump inhibitors in China: influence and future directions61 cited

Only edges whose both ends are imported exist here. Widen the year window, or show the whole map. Back to the work